Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis.

Antioxidants & redox signaling·2020
Same author

Polyphenols in Alzheimer's Disease and in the Gut-Brain Axis.

Microorganisms·2020
Same author

TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.

Biochimica et biophysica acta. Molecular basis of disease·2019
Same author

Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma.

Brain : a journal of neurology·2019
Same author

Neuropathology in Consecutive Forensic Consultation Cases with a History of Remote Traumatic Brain Injury.

Journal of Alzheimer's disease : JAD·2019
Same author

Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk.

Journal of Alzheimer's disease : JAD·2019

Related Experiment Video

Updated: Jul 9, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Oxidative stress and neurotoxicity.

Lawrence M Sayre1, George Perry, Mark A Smith

  • 1Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, USA. LMS3@case.edu

Chemical Research in Toxicology
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Oxidative stress significantly contributes to neurodegenerative diseases like Alzheimer's and Parkinson's. Differentiating early oxidative damage from secondary effects is crucial for understanding neuronal death mechanisms.

More Related Videos

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Related Experiment Videos

Last Updated: Jul 9, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Oxidative stress is increasingly recognized as a key factor in neurodegenerative diseases.
  • The central nervous system is uniquely vulnerable to oxidative damage due to its high metabolic rate and lipid content.
  • Distinguishing primary oxidative stress from secondary effects of neuronal degeneration remains a challenge.

Purpose of the Study:

  • To review the biochemical mechanisms of oxidative stress and cell death.
  • To highlight the role of oxidative stress in specific neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, ALS, and MS.
  • To differentiate diseases where oxidative stress is a primary driver of neuronal death from those where it plays a secondary role.

Main Methods:

  • Literature review and synthesis of existing research.
  • Biochemical analysis of oxidative stress pathways.
  • Comparative analysis of oxidative stress involvement across different neurodegenerative disorders.

Main Results:

  • Oxidative stress is implicated as a primary factor in neuronal death in Alzheimer's, Parkinson's, Huntington's diseases, ALS, and MS.
  • The central nervous system's susceptibility to oxidative stress is linked to its biochemical properties.
  • Evidence suggests distinct roles for oxidative stress in various neurodegenerative conditions.

Conclusions:

  • Further research is needed to elucidate the precise mechanisms and therapeutic targets of oxidative stress in neurodegeneration.
  • Developing methods to distinguish early oxidative changes is critical for effective disease intervention.
  • Understanding the primary role of oxidative stress can guide the development of novel therapeutic strategies for neurodegenerative diseases.